MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6502-350-361$20.00
Mol Pharmacol 65:350-361, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Humar, M.
Right arrow Articles by Pannen, B. H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Humar, M.
Right arrow Articles by Pannen, B. H. J.

Barbiturates Directly Inhibit the Calmodulin/Calcineurin Complex: a Novel Mechanism of Inhibition of Nuclear Factor of Activated T Cells

Matjaz Humar, Soeren E. Pischke, Torsten Loop, Alexander Hoetzel, Rene Schmidt, Christoph Klaas, Heike L. Pahl, Klaus K. Geiger, and Benedikt H. J. Pannen

Department of Anesthesiology and Critical Care Medicine, University Hospital Freiburg Freiburg, Germany (S.E.P., T.L., A.H., R.S., H.L.P., K.K.G., B.H.J.P.), and Institute of Pharmaceutical Biology, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany (C.K.)

Barbiturates are frequently used for the treatment of intracranial hypertension after brain injury but their application is associated with a profound increase in the infection rate. The mechanism of barbiturate-induced failure of protective immunity is still unknown. We provide evidence that nuclear factor of activated T cells (NFAT), an essential transcription factor in T cell activation, is a target of barbiturate-mediated immunosuppression in human T lymphocytes. Treatment of primary CD3+ lymphocytes with barbiturates inhibited the PMA and ionomycin induced increase in DNA binding of NFAT, whereas the activity of other transcription factors, such as Oct-1, SP-1, or the cAMP response element-binding protein, remained unaffected. Moreover, barbiturates suppressed the expression of a luciferase reporter gene under control of NFAT (stably transfected Jurkat T cells), and of the cytokine genes interleukin-2 and interferon-{gamma} that contain functional binding motifs for NFAT within their regulatory promotor domains (human peripheral blood CD3+ lymphocytes). Neither GABA receptor-initiated signaling nor direct interactions of barbiturates with nuclear proteins affected the activity of NFAT. In contrast, barbiturates suppressed the calcineurin-dependent dephosphorylation of NFAT in intact T cells and also inhibited the enzymatic activity of calcineurin in a cell-free system, excluding upstream regulation. Thus, our results demonstrate a novel mechanism of direct inhibition of the calcineurin/calmodulin complex that may explain some of the known immunosuppressive effects associated with barbiturate treatment.


Received May 12, 2003; accepted October 17, 2003

Address correspondence to: Dr. Benedikt H. J. Pannen, Anaesthesiologische Universitätsklinik, Hugstetterstrasse 55, D-79106 Freiburg, Germany. E-mail: pannen{at}nz.ukl.uni-freiburg.de




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Roesslein, D. Schibilsky, L. Muller, U. Goebel, C. Schwer, M. Humar, R. Schmidt, K. K. Geiger, H. L. Pahl, B. H. J. Pannen, et al.
Thiopental Protects Human T Lymphocytes from Apoptosis in Vitro via the Expression of Heat Shock Protein 70
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 217 - 225.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Humar, H. Dohrmann, P. Stein, N. Andriopoulos, U. Goebel, B. Heimrich, M. Roesslein, R. Schmidt, C. I. Schwer, A. Hoetzel, et al.
Repression of T-Cell Function by Thionamides Is Mediated by Inhibition of the Activator Protein-1/Nuclear Factor of Activated T-Cells Pathway and Is Associated with a Common Structure
Mol. Pharmacol., December 1, 2007; 72(6): 1647 - 1656.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Humar, N. Andriopoulos, S. E. Pischke, T. Loop, R. Schmidt, A. Hoetzel, M. Roesslein, H. L. Pahl, K. K. Geiger, and B. H. J. Pannen
Inhibition of Activator Protein 1 by Barbiturates Is Mediated by Differential Effects on Mitogen-Activated Protein Kinases and the Small G Proteins Ras and Rac-1
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1232 - 1240.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics